Trial Profile
Premedication With Intranasal Dexmedetomidine or Midazolam for Prevention of Emergence Agitation in Children: Superiority Randomized Clinical Trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 19 Jul 2018
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary) ; Midazolam (Primary)
- Indications Agitation
- Focus Therapeutic Use
- 12 Jul 2018 Status changed from recruiting to completed.
- 12 Sep 2017 Status changed from not yet recruiting to recruiting.
- 06 Jun 2017 New trial record